Zobrazeno 1 - 10
of 701
pro vyhledávání: '"Ichiro, Nakashima"'
Autor:
Takashi Yamamura, Noriko Isobe, Izumi Kawachi, Chiyoko Nohara, Yusei Miyazaki, Minami Tomita, Takahiko Tsumuraya, Katsuhisa Yamashita, Jin Nakahara, Ichiro Nakashima, Kazuo Fujihara
Publikováno v:
Neurology and Therapy, Vol 13, Iss 5, Pp 1361-1383 (2024)
Abstract Introduction Satralizumab, an anti-interleukin-6 receptor antibody, is approved in Japan for relapse prevention in neuromyelitis optica spectrum disorder (NMOSD) and is undergoing post-marketing surveillance (PMS) of clinical use. We aimed t
Externí odkaz:
https://doaj.org/article/cacd9763b99f4053953f8a9a3963e85e
Autor:
Juichi Fujimori, Ichiro Nakashima
Publikováno v:
Heliyon, Vol 10, Iss 6, Pp e28136- (2024)
Background: To determine which disease-modifying therapies should be used in patients with multiple sclerosis (MS), identifying patients at high and low risk for brain volume loss (BVL) is important. Although the BVL rate in MS is nearly constant fro
Externí odkaz:
https://doaj.org/article/b2efe36b135a4f8fac5863baa2a29e57
Autor:
Stephan Ortiz, Sean J. Pittock, Achim Berthele, Michael Levy, Ichiro Nakashima, Celia Oreja-Guevara, Kerstin Allen, Yasmin Mashhoon, Becky Parks, Ho Jin Kim
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
ObjectiveTo assess the pharmacokinetics and pharmacodynamics of the long-acting terminal complement 5 (C5) inhibitor ravulizumab in adults with anti-aquaporin-4 antibody-positive (AQP4+) neuromyelitis optica spectrum disorder (NMOSD) in the phase 3,
Externí odkaz:
https://doaj.org/article/b548b047f2a84fcfb67d42e621a2f960
Autor:
Tetsuya Akaishi, Ichiro Nakashima
Publikováno v:
Neural Regeneration Research, Vol 19, Iss 9, Pp 1888-1889 (2024)
Externí odkaz:
https://doaj.org/article/da43e8d34cf848de9012fb59333267ed
Autor:
Tetsuya Akaishi, Tatsuro Misu, Kazuo Fujihara, Kumi Nakaya, Naoki Nakaya, Tomohiro Nakamura, Mana Kogure, Rieko Hatanaka, Fumi Itabashi, Ikumi Kanno, Kimihiko Kaneko, Toshiyuki Takahashi, Juichi Fujimori, Yoshiki Takai, Shuhei Nishiyama, Tadashi Ishii, Masashi Aoki, Ichiro Nakashima, Atsushi Hozawa
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract White blood cell (WBC) count profiles in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4-NMOSD) and anti-myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) are still unknown. This study ev
Externí odkaz:
https://doaj.org/article/7008886e2ba74a87a069dffcecd429d7
Autor:
Kimihiko Kaneko, Hiroshi Kuroda, Yuki Matsumoto, Naohiro Sakamoto, Naoya Yamazaki, Naoki Yamamoto, Shu Umezawa, Chihiro Namatame, Hirohiko Ono, Yoshiki Takai, Toshiyuki Takahashi, Juichi Fujimori, Ichiro Nakashima, Yasuo Harigaya, Hans Lassmann, Kazuo Fujihara, Tatsuro Misu, Masashi Aoki
Publikováno v:
Neurology® Neuroimmunology & Neuroinflammation; Sep2024, Vol. 11 Issue 5, p1-6, 6p
Autor:
Ichiro Nakashima, Jin Nakahara, Hiroaki Yokote, Yasuhiro Manabe, Kazumi Okamura, Kou Hasegawa, Kazuo Fujihara
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 16 (2023)
Background: The terminal complement C5 inhibitor eculizumab is approved in Japan for relapse prevention in aquaporin-4 antibody-positive (AQP4+) neuromyelitis optica spectrum disorder (NMOSD) and is undergoing mandatory post-marketing surveillance (P
Externí odkaz:
https://doaj.org/article/be2999c2978d49bba3a3526b7b8d1cc4
Autor:
Kuniko Kohyama, Hiroya Nishida, Kimihiko Kaneko, Tatsuro Misu, Ichiro Nakashima, Hiroshi Sakuma
Publikováno v:
Frontiers in Neuroscience, Vol 17 (2023)
BackgroundThe autoantibody to myelin oligodendrocyte glycoprotein (MOG), a component of the central nervous system myelin, has been identified in a subset of demyelinating diseases. However, there is no convincing evidence to support the direct patho
Externí odkaz:
https://doaj.org/article/a63c5e6d32f44a16b07631de153f4c0f
Publikováno v:
Internal Medicine; 2024, Vol. 63 Issue 13, p1939-1943, 5p
Autor:
Tetsuya Akaishi, Tatsuro Misu, Kazuo Fujihara, Naoki Nakaya, Tomohiro Nakamura, Mana Kogure, Rieko Hatanaka, Fumi Itabashi, Ikumi Kanno, Toshiyuki Takahashi, Hiroshi Kuroda, Juichi Fujimori, Yoshiki Takai, Shuhei Nishiyama, Kimihiko Kaneko, Tadashi Ishii, Masashi Aoki, Ichiro Nakashima, Atsushi Hozawa
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Multiple sclerosis (MS) is a major demyelinating disease of the central nervous system; however, its exact mechanism is unknown. This study aimed to elucidate the profile of white blood cells (WBCs) in the acute phase of an MS attack. Sixty-
Externí odkaz:
https://doaj.org/article/dfa9aee74d564861b2f98ebcbdf9c0b3